The stock price for Anavex Life Sciences Corporation (AVXL) currently stands at $7.00. The stock experienced a substantial increase in the last session, hitting $7.0747 after starting at $7.00. The stock’s lowest price was $6.62 before closing at $6.27.
Anavex Life Sciences Corporation saw a rather unpredictable run in, in terms of market performance. The company’s stock reached its highest point at $13.25 on 12/02/22, while the lowest price for the same duration was marked at $4.90 on 10/23/23.
52-week price history of AVXL Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Anavex Life Sciences Corporation’s current trading price is -47.17% away from its 52-week high, while its distance from the 52-week low is 42.86%. The stock’s price range during this period has spanned from $4.90 to $13.25. In the Healthcare sector, the Anavex Life Sciences Corporation’s shares surpassed a trading volume of approximately 2.15 million for the day, which was noticeably higher compared to the average daily volume of 9.0.88 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Anavex Life Sciences Corporation (AVXL) has experienced a quarterly decline of -14.00% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 573.65M and boasts a workforce of 38 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 7.22, with a change in price of -0.91. Similarly, Anavex Life Sciences Corporation recorded 866,351 in trading volume during the last 100 days, posting a change of -11.50%.
Examining AVXL’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for AVXL stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
AVXL Stock Stochastic Average
Today’s raw stochastic average for Anavex Life Sciences Corporation over the last 50 days is 60.17%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 96.43%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 82.55% and 79.89%, respectively.
AVXL Stock Price Performance Analysis
The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. This year’s metric has recorded a Price decrease of -24.41%. However, over the past six months, we’ve seen a stronger performance of -26.32%. The price of AVXL fallen by 34.62% over the last 30 days. And in the last five days, it has surged by 21.74%.